Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial - Ferreri, A J; Cwynarski, K; Pulczynski, E (Lancet Haematol, 2016)
, et al; International Extranodal Lymphoma Study Group (IELSG).